newsfilter
← Latest News
GlobeNewswire·

Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference

MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related